Menu

Report Library

All Reports
Datamonitor Healthcare Oncology: Prostate Cancer Pricing & Reimbursement

Retail Price: $2,995.00

*BioMedTracker Subscriber Price: $2,095.00 - click here to log in

June 01, 2018

Interviewed payers in the US and five major EU markets (France, Germany, Italy, Spain and the UK) express concern surrounding the significant and rising cost of prostate cancer treatment. Payers highlight the large and growing epidemiology of the disease, as well as the rising costs associated with the use of expensive novel anti-androgens in earlier treatment lines.

This Datamonitor Healthcare report contains a Pricing & Reimbursement module.

Disease Group Covered: Oncology
Back to the top Back to the top